- $550.60m
- $1.40bn
- $1.88bn
NYSE ORDER IMBALANCE 61029.0 SHARES ON BUY SIDE
Evolent Health Inc reports results for the quarter ended in September - Earnings Summary
Brief: Evolent Health Announces Third Quarter 2022 Results
Evolent Health Inc expected to post earnings of 12cents a share - Earnings Preview
Street View: UnitedHealth's strong results set tone for peers
NYSE ORDER IMBALANCE 136069.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 65836.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 97622.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 65858.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 55867.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 119689.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 118540.0 SHARES ON SELL SIDE
Teladoc, American Well rise as sun sets on Amazon's telehealth unit
Teladoc, American Well rise as Amazon shutters virtual healthcare service
U.S. RESEARCH ROUNDUP- Banco De Chile, Enviva, ZTO Express
Brief: Evolent Health entered into separate privately negotiated exchange agreements
Brief: Evolent Health Files For Stock Shelf Offering By Selling Stockholders
Brief: Evolent Health Files For Resale Of Up To 3.7 Mln Shares OF Class A Common Stock
U.S. RESEARCH ROUNDUP-Esperion Therapeutics, Sierra Wireless, WW Grainger